Christchurch Womens Hospital Christchurch

Christchurch, New Zealand

Christchurch Womens Hospital Christchurch

Christchurch, New Zealand
SEARCH FILTERS
Time filter
Source Type

Simcock B.,Peter MacCallum Cancer Center | Simcock B.,Christchurch Womens Hospital Christchurch | Narayan K.,Peter MacCallum Cancer Center | Drummond E.,Peter MacCallum Cancer Center | And 3 more authors.
International Journal of Gynecological Cancer | Year: 2015

Objective The optimal method of assessing disease distribution in endometrial cancer is widely debated. Knowledge of disease distribution assists in planning adjuvant radiotherapy; in this study we used positron emission tomography/computed tomography (PET/CT) to assess disease distribution before radiotherapy. Methods Seventy-three consecutive patients referred to the Peter MacCallum Cancer Centre for adjuvant radiotherapy for endometrial cancer, with either high-risk disease after a hysterectomy or recurrent disease, had a PET/CT before treatment. The findings on PET/CT and clinical course were recorded. Results PET/CT found additional disease in 35% of postoperative patients, changing planned treatment in 31%. In the group with known recurrence, additional disease was found in 72%, changing management in 36%. Conclusions PET/CT is a valuable tool for planning radiotherapy in endometrial cancer. © 2015 by IGCS and ESGO.

Loading Christchurch Womens Hospital Christchurch collaborators
Loading Christchurch Womens Hospital Christchurch collaborators